Mel Sorensen
President and CEO, Director · Galera Therapeutics, Inc.
IndividualSelling only
- 2025
- Aug 5, 2026
- 2
Other insiders active in the same sector
No other insider has filed at Mel Sorensen's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Charles N. Mills - $74.80M in MDLN purchases and sales in the last 12 months
- Keith A. Meister - $74.03M in WGS purchases and sales in the last 12 months
- Warren B. Kanders - $73.88M in CDRE purchases and sales in the last 12 months
- Amirali Talasaz - $73.75M in GH purchases and sales in the last 12 months
- L1 Capital Pty Ltd - $72.66M in AVR purchases and sales in the last 12 months
- James E. Flynn - $70.87M in NUVL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Mel Sorensen?
Mel Sorensen is a corporate insider, tracked as President and CEO, Director of Galera Therapeutics, Inc. (GRTX). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Mel Sorensen submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Mel Sorensen been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($1K) across all tracked filings.
